Head of FDA’s ORA Worried Budget Woes Could Lead to Fewer Inspections

Shouldering the cost of FY25 federal employee pay increases may cause the FDA’s Office of Regulatory Affairs (ORA) to reduce the number of inspections it can conduct, said the office’s Associate Commissioner for Regulatory Affairs Michael Rogers during an Alliance for a Stronger FDA webinar Wednesday.
Source: Drug Industry Daily